JFB and XTEND Announce $1.5B Business Combination to Establish a Nasdaq-Listed US Leader in AI-Driven Autonomous Defense Robotics Strategic investors in the merger include Eric Trump, Unusual Machines (NYSE: UMAC), American Ventures, LLC, Protego Ventures, Aliya Capital and Agostinelli Group. Implied acquisition value of $1.5 billion, based on the price paid per share in concurrent private placement. Merger to create

Adds to executive focus on early clinical development and deepens medical and scientific partnership with clients DURHAM, N.C., Feb. 17, 2026 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced it has expanded its executive team. Oren Cohen, MD who previously served as both Fortrea’s chief medical officer (CMO) and president of Clinical Pharmacology

Titan 2.0: The New Rules of Power, Legacy, and Impact His Excellency Dr. Thani bin Ahmed Al Zeyoudi MINISTER OF FOREIGN TRADE & PRESIDENT OF AIM CONGRESS DUBAI, United Arab Emirates, Feb. 17, 2026 (GLOBE NEWSWIRE) — Tycoons, an initiative of the AIM Global Foundation, will convene for the first time in Dubai on 12 April 2026 as part of